152 employees
Pluristem Therapeutics is a biotherapy company using placental cells and a 3D technology platform to develop cell therapies for diseases.
2003
$54M
from 1 investors over 1 rounds
Pluristem Therapeutics raised $54M on April 24, 2020
Investors: European Investment Bank